Invesco Ltd. Nevro Corp Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Nevro Corp stock. As of the latest transaction made, Invesco Ltd. holds 51,660 shares of NVRO stock, worth $235,053. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,660

Previous 53,317 3.11%

Holding current value

$235,053

Previous $448,000 35.71%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$4.71 - $10.1 $7,804 - $16,735	-1,657 Reduced 3.11%	51,660 $288,000
Q2 2024 Aug 13, 2024	SELL	$7.96 - $13.59 $7,585 - $12,951	-953 Reduced 1.76%	53,317 $448,000
Q1 2024 May 14, 2024	SELL	$13.56 - $20.78 $12 Million - $18.5 Million	-888,201 Reduced 94.24%	54,270 $783,000
Q4 2023 Feb 12, 2024	SELL	$14.18 - $22.31 $1.5 Million - $2.36 Million	-105,627 Reduced 10.08%	942,471 $20.3 Million
Q3 2023 Nov 13, 2023	BUY	$18.22 - $25.85 $4,591 - $6,514	252 Added 0.02%	1,048,098 $20.1 Million
Q2 2023 Aug 11, 2023	SELL	$22.62 - $39.32 $67,023 - $116,505	-2,963 Reduced 0.28%	1,047,846 $26.6 Million
Q1 2023 May 12, 2023	BUY	$30.17 - $41.11 $260,457 - $354,902	8,633 Added 0.83%	1,050,809 $38 Million
Q4 2022 Feb 13, 2023	SELL	$36.43 - $49.4 $73,042 - $99,047	-2,005 Reduced 0.19%	1,042,176 $41.3 Million
Q3 2022 Nov 14, 2022	BUY	$40.66 - $53.03 $49,889 - $65,067	1,227 Added 0.12%	1,044,181 $48.7 Million
Q2 2022 Aug 15, 2022	BUY	$40.85 - $77.67 $80,923 - $153,864	1,981 Added 0.19%	1,042,954 $45.7 Million
Q1 2022 May 16, 2022	BUY	$59.95 - $92.06 $379,063 - $582,095	6,323 Added 0.61%	1,040,973 $75.3 Million
Q4 2021 Feb 14, 2022	SELL	$81.07 - $121.29 $30.4 Million - $45.6 Million	-375,592 Reduced 26.63%	1,034,650 $83.9 Million
Q3 2021 Nov 15, 2021	SELL	$101.99 - $166.36 $902,815 - $1.47 Million	-8,852 Reduced 0.62%	1,410,242 $164 Million
Q2 2021 Aug 17, 2021	BUY	$141.6 - $179.06 $1.11 Million - $1.4 Million	7,819 Added 0.55%	1,419,094 $235 Million
Q1 2021 May 17, 2021	SELL	$132.81 - $182.18 $6.35 Million - $8.71 Million	-47,799 Reduced 3.28%	1,411,275 $197 Million
Q4 2020 Feb 16, 2021	BUY	$138.17 - $184.34 $781,904 - $1.04 Million	5,659 Added 0.39%	1,459,074 $253 Million
Q3 2020 Nov 16, 2020	SELL	$114.09 - $145.51 $1.47 Million - $1.88 Million	-12,915 Reduced 0.88%	1,453,415 $202 Million
Q2 2020 Aug 14, 2020	BUY	$89.45 - $129.85 $4.22 Million - $6.12 Million	47,143 Added 3.32%	1,466,330 $175 Million
Q1 2020 May 15, 2020	SELL	$70.23 - $144.31 $2.83 Million - $5.82 Million	-40,296 Reduced 2.76%	1,419,187 $142 Million
Q4 2019 Feb 14, 2020	SELL	$76.41 - $117.54 $40.1 Million - $61.7 Million	-525,226 Reduced 26.46%	1,459,483 $172 Million
Q3 2019 Nov 14, 2019	BUY	$61.52 - $91.1 $845,284 - $1.25 Million	13,740 Added 0.7%	1,984,709 $171 Million
Q2 2019 Aug 14, 2019	BUY	$58.04 - $66.99 $86.9 Million - $100 Million	1,497,455 Added 316.24%	1,970,969 $128 Million
Q1 2019 May 15, 2019	BUY	$35.52 - $62.62 $114,836 - $202,450	3,233 Added 0.69%	473,514 $29.6 Million
Q4 2018 Feb 14, 2019	BUY	$35.43 - $56.29 $16.7 Million - $26.5 Million	470,281 New	470,281 $18.3 Million

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $161M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account